Plutux
$0.84
+3.86%
N/A+$0.03
Healthcare
Biotechnology
NASDAQ
Active Trading

Adagio Therapeutics, Inc., a biopharmaceutical firm in its clinical development phase, operates within the United States, specializing in the discovery, progression, and ...

Plutux is not an investment adviser. Market data and AI-generated analysis are for information and education only, not investment advice. Disclaimer

© Plutux Technology Limited 2026